Compare ARMK & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARMK | MEDP |
|---|---|---|
| Founded | 1959 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.2B | 16.6B |
| IPO Year | 2013 | 2016 |
| Metric | ARMK | MEDP |
|---|---|---|
| Price | $56.47 | $614.91 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 12 |
| Target Price | $47.88 | ★ $473.17 |
| AVG Volume (30 Days) | ★ 1.9M | 180.7K |
| Earning Date | 05-12-2026 | 04-22-2026 |
| Dividend Yield | ★ 1.07% | N/A |
| EPS Growth | ★ 23.23 | 20.98 |
| EPS | 1.11 | ★ 8.53 |
| Revenue | ★ $18,506,299,000.00 | N/A |
| Revenue This Year | $8.71 | $13.19 |
| Revenue Next Year | $6.57 | $7.75 |
| P/E Ratio | ★ $51.25 | $72.12 |
| Revenue Growth | ★ 6.35 | N/A |
| 52 Week Low | $35.07 | $373.00 |
| 52 Week High | $62.65 | $677.90 |
| Indicator | ARMK | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 39.80 | 57.60 |
| Support Level | $55.44 | $575.89 |
| Resistance Level | $58.58 | $629.30 |
| Average True Range (ATR) | 1.25 | 13.13 |
| MACD | -0.15 | 0.82 |
| Stochastic Oscillator | 2.96 | 69.45 |
Aramark, founded in 1936 and headquartered in Philadelphia, Pennsylvania, is a foodservice company that provides facility management and workplace solutions. The company primarily generates revenue from its North American food and support services segment, serving clients such as schools, healthcare facilities, and entertainment venues.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.